share_log

JonesTrading Initiates Coverage On Janux Therapeutics With Buy Rating, Announces Price Target of $70

Moomoo 24/7 ·  Apr 16 06:50

JonesTrading analyst Soumit Roy initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price Target of $70.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment